EUVIMEDEUVIMED entdecken
Fallbericht

Marked Skin Prick Test Reactivity During Selective IL-23p19 Inhibition: A Case Report

Yandy Marx Castillo-Aleman, Maria Mitzi Jumagdao, Florengel Pada Ternola, Sujatha Chankramath

Cureus · 15.11.2026

DOI: 10.7759/cureus.119712 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 15.11.2026. Verfasst von Yandy Marx Castillo-Aleman und 3 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Skin prick testing (SPT) is widely used to identify immunoglobulin E (IgE)-mediated sensitization, although wheal size alone does not independently establish clinical allergy. We report a 27-year-old man with longstanding food allergy and Crohn’s disease who experienced clinically significant worsening of pre-existing allergic rhinoconjunctivitis during maintenance therapy with guselkumab, a selective IL-23p19 inhibitor, and exhibited markedly pronounced SPT responses to multiple unrelated aeroallergens and foods, with wheal diameters reaching 45 mm. Despite marked cutaneous reactivity, clinical correlation varied substantially among food allergens: some sensitizations corresponded to established clinical allergy, whereas others occurred despite regular asymptomatic consumption. Notably, worsening allergic rhinoconjunctivitis requiring allergen immunotherapy and pronounced immediate cutaneous reactivity were observed during ongoing IL-23 inhibition. This observation is of interest in light of the proposed role of IL-23 in Th2-associated allergic inflammation and emerging reports of worsening allergic disease during IL-23-directed therapy. Although causality cannot be inferred from a single case, this report documents pronounced IgE-mediated cutaneous reactivity during IL-23 inhibition and supports further investigation into the effects of this therapy on established allergic disease.

Zitieren

APA

Castillo-Aleman, Y. M., Jumagdao, M. M., Ternola, F. P., & Chankramath, S. (2026). Marked Skin Prick Test Reactivity During Selective IL-23p19 Inhibition: A Case Report. Cureus. https://doi.org/10.7759/cureus.119712

Vancouver

Castillo-Aleman YM, Jumagdao MM, Ternola FP, Chankramath S. Marked Skin Prick Test Reactivity During Selective IL-23p19 Inhibition: A Case Report. Cureus. 2026. doi:10.7759/cureus.119712

BibTeX
@article{CastilloAleman2026,
  author = {Castillo-Aleman, Yandy Marx and Jumagdao, Maria Mitzi and Ternola, Florengel Pada and Chankramath, Sujatha},
  title = {Marked Skin Prick Test Reactivity During Selective IL-23p19 Inhibition: A Case Report},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.119712}
}
Kostenlos starten →